- Home
- IPST vs XAIR Comparison
IPST vs XAIR Comparison
Compare IPST & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IPST | XAIR |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0M | 3.0M |
| IPO Year | 2024 | 2015 |
Fundamental Metrics
Financial Performance| Metric | IPST | XAIR |
|---|---|---|
| Price | $2.69 | $2.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | ★ 256.5K | 58.2K |
| Earning Date | 11-17-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $8,402,488.00 | $7,679,000.00 |
| Revenue This Year | $66.82 | $4.23 |
| Revenue Next Year | $60.33 | $108.84 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 5.41 | ★ 107.26 |
| 52 Week Low | $0.26 | $0.33 |
| 52 Week High | $308.00 | $8.19 |
Technical Indicators
Market Signals| Indicator | IPST | XAIR |
|---|---|---|
| Relative Strength Index (RSI) | 42.83 | 36.92 |
| Support Level | $2.51 | $2.05 |
| Resistance Level | $2.80 | $3.30 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | 0.03 | 0.05 |
| Stochastic Oscillator | 40.18 | 17.02 |
Price Performance
Historical ComparisonAbout IPST Heritage Distilling Holding Company Inc.
IP Strategy Holdings Inc operate a diversified business centered on digital asset-based infrastructure and intellectual property (IP) management, supplemented by a legacy craft spirits operating segment. The Company provides public market investors with broad exposure to the around $80 trillion programmable intellectual property economy in a regulated equity format. Its treasury reserve of $IP tokens provides direct participation in the Story ecosystem, which enables on-chain registration, licensing, and monetization of intellectual property.
About XAIR Beyond Air Inc.
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.